Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Phase 2 Study of FP-10, the Food Ingredient Derived From Milk Casein, on the Eradication Rates of Helicobacter Pylori by a Triple Therapy With Lansoprazole, Amoxicillin, and Clarithromycin

NCT00281047 is registered in ClinicalTrials.gov with Hamamatsu University as lead sponsor.

NCT NCT00281047
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00281047 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Phase 2 Study of FP-10, the Food Ingredient Derived From Milk Casein, on the Eradication Rates of Helicobacter Pylori by a Triple Therapy With Lansoprazole, Amoxicillin, and Clarithromycin
Lead sponsor
Hamamatsu University
Phase
Phase 2/3
Overall status
Unknown status
Start date
January 31, 2006
Completion date
May 31, 2006
Enrollment
138
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

helicobacter pylori